Hydroxypyridoxazepines as NRF2 activators

JP7602469B2Active Publication Date: 2024-12-18GLAXOSMITHKLINE INTPROP DEV LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2021547429
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-11-07
Filing Date
2020-02-11
Publication Date
2024-12-18
Estimated Expiration
2040-02-11

Smart Images

  • Figure 0007602469000080
    Figure 0007602469000080
  • Figure 0007602469000081
    Figure 0007602469000081
  • Figure 0007602469000082
    Figure 0007602469000082
Patent Text Reader

Abstract

The present invention relates to hydroxypyridoxazepine compounds, methods for preparing them, pharmaceutical compositions containing them, and their use as Nrf2 activators. In particular, the present invention relates to a compound of formula (I), and its pharmaceutically acceptable salts, tautomers, or hydrates thereof:
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Nrf2 regulator

    JP2017503786A

  • NRF2 regulator

    JP2018517731A

  • NRF2 compounds

    WO2018109646A1